journal article
Dec 01, 1981
Primary liver cancer and its relationship to chronic infection with the hepatitis B virus
Springer Seminars in Immunopathology
Vol. 3
No. 4
pp. 473-485
·
Springer Science and Business Media LLC
Topics
No keywords indexed for this article. Browse by subject →
References
52
[1]
Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB (1979) Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282: 615
10.1038/282615a0
[2]
Allen DW, Cole P (1972) Viruses and human cancer. N Engl J Med 286: 70
10.1056/nejm197201132860206
[3]
Anthony PP, Vogel CL, Barker LF (1973) Liver cell dysplasia: a premalignant condition. J Clin Pathol 26: 217
10.1136/jcp.26.3.217
[4]
Bagshawe AF, Gasengi DM, Cameron CH, Dorman J, Dane DS (1976) Hepatitis Bs antigen and liver cancer. A population-based study in Kenya. Br J Cancer 31: 581
10.1038/bjc.1975.99
[5]
Dudley FJ, Scheuer PJ, Sherlock S (1973) Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet II: 1388
[6]
Chakraborty PR, Ruiz-Opazo N, Shouval D, Shafritz DA (to be published) Identification of integrated hepatitis B virus DNA and expression of viral RNA in a human hepatocellular carcinoma cell line which produces hepatitis B surface antigen. Nature
[7]
Farber E (1976) On the pathogenesis of experimental hepatocellular carcinoma. In: Okuda K, Peters RL (eds) Hepatocellular carcinoma. J. Wiley, New York, p 3
[8]
Farber E (1978) Experimental liver carcinogenesis: a perspective. In: Remmer H, Bolt HM, Bannasch P, Popper H (eds) Primary liver tumors. MTP Press, Lancaster, p 357
[9]
Hadziyannis S (1980) Hepatocellular carcinoma and type B hepatitis. Clin Gastroenterol 9: 117
10.1016/s0300-5089(21)00709-4
[10]
Hadziyannis S (to be published) The “ground-glass” hepatocyte: An aid to diagnosis — a challenge to pathophysiology. In: Berk PD (ed) Frontiers in liver disease. Thieme-Stratton, New York
[11]
Hadziyannis S, Trichopoulos D (1978) Hepatocellular carcinoma in Greece and its relationship to the hepatitis B virus. In: Remmer H, Bolt HM, Bannasch P, Popper H (eds) Primary liver tumors. MTP Press, Lancaster, p 431
[12]
Hadziyannis S, Merikas GE, Afroudakis AP (1970) Hepatitis-associated antigen in chronic liver disease. Lancet II: 100
10.1016/s0140-6736(70)92672-3
[13]
Hadziyannis S, Gerber MA, Vissoulis C, Popper H (1973) Cytoplasmic hepatitis B antigen in “ground-glass” hepatocytes of carriers. Arch Pathol 96: 327
[14]
Hadziyannis S, Giustozi A, Moussouros A, Merikas G (1976) Hepatitis B core and surface antigens in the liver in primary liver cell carcinoma. In: Leevy CM (ed) Diseases of the liver and biliary tract, S. Karger, Basel, p 174
[15]
Hadziyannis S, Karvoutzis G, Manessis E, Dorn J, Merikas G (1979) Surveillance of patients with chronic liver disease by serial testing for serum a1-fetoprotein. In: Lehman FG (ed) Carcinoembryonic proteins. Vol. II. Elsevier Biomedical Press, Holland, p 403
[16]
Hoofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ, VA Hepatitis Cooperative Study Group (1978) Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 298: 1379
10.1056/nejm197806222982502
[17]
Kew MC (1978) Hepatocellular cancer in Southern Africa. In: Remmer H, Bolt HM, Bannasch P, Popper H (eds) Primary liver tumors. MTP Press, Lancaster, p 170
[18]
Kew MC, Geddes EN, Macnab GM, Bersohn I (1974) Hepatitis-B antigen and cirrhosis in Bantu patients with primary liver cancer. Cancer 34: 539
10.1002/1097-0142(197409)34:3<539::aid-cncr2820340310>3.0.co;2-3
[19]
Kojima M, Udo K, Takahashi Y, Yashizawa H, Tsuda F, Itoh Y, Miyakawa Y, Mayumi M (1977) Correlation between titer of antibody to hepatitis B core antigen and presence of viral antigens in the liver. Gastroenterology 73: 664
10.1016/s0016-5085(19)31762-7
[20]
Kubo Y, Okuda K, Hashimoto M, Nagasaki Y, Ebata H, Nakajima Y, Musha H, Sakuma K, Ohtake H (1977) Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma. Gastroenterology 72: 1217
10.1016/s0016-5085(77)80014-0
[21]
Kubo U, Okuda K, Musha H, Nakashima T (1978) Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease. Gastroenterology 74: 578
10.1016/0016-5085(78)90299-8
[22]
Lapis K, Beard D, Beard JW (1975) Transplantation of hepatomas induced in the avian liver by MC29 leukosis virus. Cancer Res 35: 132
[23]
Lehman FG (1975) Early detection of hepatoma: prospective study in liver cirrhosis using passive hemagglutination and the radioimmunoassay. Ann NY Acad Sci 259: 196
10.1111/j.1749-6632.1975.tb25414.x
[24]
Macnab GM, Alexander JJ, Lecatsas G, Bey EM, Urbanowicz JM (1976) Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer 34: 509
10.1038/bjc.1976.205
[25]
Manessis E, Hadziyannis S, Karvoutzis G, Merikas G (1976) Epidemiological observations on primary liver cancer in Greece. Proceedings of the Fourth Panhellenic Congress of Gastroenterology. P Paschalides, Athens p 859
[26]
Manessis E, Hadziyannis S, Karvoutzis G, Moussouros A, Merikas G (1977) HBsAg positive and HBsAg negative hepatocellular carcinoma in Greece. Arc. Hellenic Med. Soc. Supplement Vol. 3: 4
[27]
Nazarewicz T, Krawczynski K, Slusarczyk J, Nowoslawski A (1977) Cellular localization of hepatits B virus antigen in patients with hepatocellular carcinoma coexisting with liver cirrhosis. J Infect Dis 135: 298
10.1093/infdis/135.2.298
[28]
Okuda K (1976) Clinical aspects of hepatocellular carcinoma. Analysis of 134 cases. In: Okuda K, Peters RL (eds) Hepatocellular carcinoma. J. Wiley, New York, p 387
[29]
Okuda K, Kotoda K, Obota H, Hayashi N, Hisamitsu T, Tamiya M, Kubo Y, Yakushiji F, Nagata E, Jinnouchi S, Shimokawa Y (1975) Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum a1-fetoprotein levels. Gastroenterology 69: 226
10.1016/s0016-5085(19)32658-7
[30]
Peters RL, Afroudakis AP, Tatter D (1977) The changing incidence of association of hepatitis B with hepatocellular carcinoma in California. Am J Clin Pathol 68: 1
10.1093/ajcp/68.1.1
[31]
Popper H (1978) The increasing importance of liver tumors. In: Remer H, Bolt HM, Bannasch P, Popper H (eds) Primary liver tumors, MTP Press, Lancaster, p 3
[32]
Primack A, Vogel CL, Barker LF (1973) Immunologic studies in Uganda patients with hepatocellular carcinoma. Br Med J 1: 16
10.1136/bmj.1.5844.16
[33]
Prince AM (1971) Role of serum hepatitis virus in chronic liver disease. Gastroenterology 60: 913
10.1016/s0016-5085(71)80093-8
[34]
Prince AM, Szmuness W, Michon J, Diebolt G, Linhard J, Quenum C, Sankale M (1975) A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal. Int J Cancer 16: 376
10.1002/ijc.2910160304
[35]
Reed WD, Eddleston ALWF, Stern RB, Williams R, Zuckerman AJ, Bowes A, Earl PM (1973) Detection of hepatitis B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain. Lancet II: 690
10.1016/s0140-6736(73)92534-8
[36]
Sherlock S, Fox RA, Niazi SP, Sheuer PJ (1970) Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet I: 1243
10.1016/s0140-6736(70)91737-x
[37]
Shikata T (1976) Primary liver carcinoma and liver cirrhosis. In: Okuda K, Peters RL (eds) Hepatocellular carcinoma, J. Wiley, New York, p 53
[38]
Skelly J, Copeland JA, Howard CR, Zuckerman AJ (1979) Hepatitis B surface antigen produced by a human hepatoma cell line. Nature 282: 617
10.1038/282617a0
[39]
Skinhoj P, Hansesn JPH, Nielsen MH, Mikkelsen F (1978) Occurrence of cirrhosis and primary liver cancer in an Eskimo population hyperendemically infected with hepatitis B virus. Am J Epidemiol 108: 121
10.1093/oxfordjournals.aje.a112595
[40]
Summers J, O'Connell A, Maupas P, Coudeau A, Coursaget P, Drucker J (1978) Hepatitis B virus DNA in primary hepatocellular carcinoma tissue. J Med Virol 2: 207
10.1002/jmv.1890020304
[41]
Summers J, Smolec JM, Snyder RA (1978) A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 75: 4533
10.1073/pnas.75.9.4533
[42]
Sutnick AI, Millman L, London WT, Blumberg BS (1972) The role of Australia antigen in viral hepatitis and other diseases. Annu Rev Med 23: 161
10.1146/annurev.me.23.020172.001113
[43]
Szmuness W (1978) Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 24: 40
[44]
Szmuness W, Stevens CE, Ikram H, Much MI, Harley EJ, Hollinger B (1978) Prevalence of hepatitis B virus infection and hepatocellulax carcinoma in Chinese-Americans. J Infect Dis 137: 822
10.1093/infdis/137.6.822
[45]
Tabor E, Gerety RJ, Vogel CL, Boyley AC, Anthony PP, Chan CH, Barker LF (1977) Hepatitis B virus infection and primary hepatocellular carcinoma. J Natl Cancer Inst 58: 1197
10.1093/jnci/58.5.1197
[46]
Thung SM, Gerber MA, Sarno E, Popper H (1979) Distribution of five antigens in hepatocellular carcinoma. Lab Invest 41: 101
[47]
Trichopoulos D, Papaevangelou G, Violaki M, Vissoulis Ch, Sparros L, Manousos O (1976) Geographical correlation between mortality from primary hepatic carcinoma and prevalence of hepatitis B surface antigen in Greece. Br J Cancer 34: 83
10.1038/bjc.1976.125
[48]
Trichopoulos D, Tabor E, Gerety RJ, Xirouchaki E, Sparros L, Munoz N, Linsell CA (1978) Hepatitis B and primary hepatocellular carcinoma in European populations. Lancet II: 1217
10.1016/s0140-6736(78)92097-4
[49]
Trichopoulos D (to be published) The causes of primary hepatocellular carcinoma in man. Prog Med Virol
[50]
Vogel L, Anthony PP, Mody N, Barker LF (1970) Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet II: 621
10.1016/s0140-6736(70)91396-6
Showing 50 of 52 references
Metrics
6
Citations
52
References
Details
- Published
- Dec 01, 1981
- Vol/Issue
- 3(4)
- Pages
- 473-485
- License
- View
Authors
Cite This Article
Stephanos J. Hadziyannis (1981). Primary liver cancer and its relationship to chronic infection with the hepatitis B virus. Springer Seminars in Immunopathology, 3(4), 473-485. https://doi.org/10.1007/bf01951494